Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)

Launched by ANRS, EMERGING INFECTIOUS DISEASES · Mar 18, 2025

Keywords

ClinConnect Summary

The French Tuberculosis Cohort study, also known as FrenchTB, is designed to follow people who have recently been diagnosed with tuberculosis (TB) and are starting treatment. This study aims to collect various health information over time to better understand how TB treatments work. Participants will be adults aged 18 and older who have been diagnosed with TB and are beginning their treatment. They will need to provide consent to join the study, and if they are unable to do so, a family member may give consent for them in certain serious cases.

If you join the study, you will attend several scheduled visits over the course of your treatment, where healthcare professionals will collect information about your health and may take samples like blood, urine, and even hair. This study is not yet recruiting participants, so it’s important to check back for updates if you or a loved one are interested. Your involvement will help researchers learn more about TB and improve treatment for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged ≥18 years.
• • Diagnosis of tuberculosis by microbiological or clinical means, including on the basis of a pathological examination for extrapulmonary tuberculosis leading to a Compulsory Declaration (CD) and treated for less than 8 days.
• • Have signed a voluntary, informed and written consent (at the latest on the day of inclusion and before any examination carried out as part of the research), or alternatively, consent from relatives in cases of tuberculous meningitis or other serious forms of tuberculosis with impaired consciousness or confusion, until the person is able to give their consent.
• Exclusion Criteria:
• • Presence of significant cognitive impairment that, in the opinion of the site investigator or designated person, may affect the ability to give reliable informed consent (except in the specific case of meningeal tuberculosis).